Abstract 610: Blockade of tumor expression of PD-1 promotes lung cancer growth in a murine model

Abstract Lung cancer remains one of the most prevalent and fatal malignancies worldwide. There are substantial evidences that immunotherapies offer significant benefits among lung cancer patients. Pembrolizumab, a humanized programmed death receptor-1(anti-PD-1) antibody is now approved by FDA as a...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 77; no. 13_Supplement; p. 610
Main Authors Du, Shisuo, Guan, Qing, Dicker, Adam P., LU, Bo
Format Journal Article
LanguageEnglish
Published 01.07.2017
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first